Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. (2020)

First Author: Rajoli RK
Attributed to:  MICA: New combination therapy against MDR TB targeting the respiratory chain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.05.01.20087130

PubMed Identifier: 32511548

Publication URI: http://europepmc.org/abstract/MED/32511548

Type: Journal Article/Review

Parent Publication: medRxiv : the preprint server for health sciences